U.S. market Closed. Opens in 11 hours 33 minutes

BXRX | Baudax Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue1.27M1.08M493.00KN/AN/AN/A
Cost of Revenue7.01M2.44M1.73MN/AN/AN/A
Gross Profit-5.74M-1.36M-1.24MN/AN/AN/A
Operating Expenses30.00M51.01M54.57M47.07M65.04M48.26M
Selling, General & Admin24.12M45.31M43.34M27.01M29.45M19.63M
Research & Development3.89M3.12M9.09M20.06M35.58M28.64M
Other Operating Expenses2.00M2.58M2.15M-38.00K-132.00KN/A
Operating Income-56.81M-19.01M-74.79M-32.52M-73.53M-61.10M
Other Expenses / Income-1.98M-763.00K-1.31M-38.00K-8.63M16.00K
Before Tax Income-58.80M-19.77M-76.10M-32.56M-73.67M-61.08M
Income Tax Expenses23.05M3.84M1.40M-14.55M-132.00KN/A
Net Income-58.80M-19.77M-76.10M-18.00M-73.67M-61.08M
Interest Expenses21.07M2.30M1.36MN/AN/AN/A
Basic Shares Outstanding331.62K54.74K13.31K6.68K6.48K4.00
Diluted Shares Outstanding331.62K54.74K13.31K6.68K6.48K4.00
EBITDA-12.68M-48.26M-53.21M-61.15M-56.14M-61.01M
EBITDA Margin-998.90%-4,468.52%-10,792.70%0.00%0.00%0.00%
EBIT-14.67M-13.62M-73.34M-32.56M-73.80M-61.08M
EBIT Margin-1,156.26%-1,261.39%-14,875.66%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙